Space companies have brought in just over $2 billion in private investment so far this year, according to Space Angels. 101 likes.

While the former reached orbit in January, the latter three are each deep into rocket testing programs, with the suborbital and orbital test launches scheduled in the coming months. Viela Bio, based in Gaithersburg, Maryland, spun out of AstraZeneca Pharmaceuticals LP’s MedImmune with a Series A financing of up to $250 million. Why Astra built a space startup and rocket factory in Silicon Valley. TechCrunch ist jetzt Teil der Verizon Media-Familie. The round was co-led by 6 Dimensions Capital, Boyu Capital and Hillhouse Capital.Temasek and Sirona Capital participated. Michael Sheetz China is upping bets on private space companies, leading among countries expanding market share in the nascent industry during the third quarter, according a report from Space Angels, an investing firm specializing in private space ventures. China Increases Investment in Emerging Private Space Industry . Viela Bio will focus on inflammatory and autoimmune diseases. Astra encounters anomaly during pre-launch testing, will evaluate options for next attempt | Rocket launch startup Astra, which had been attempting to claim DARPA’s prize for successful demonstration of flexible space launch capabilities until Rocket Lab, Vector, Virgin Orbit and Astra Space. ASTRA - Australian Short Term Rental Accommodation Association. AstraZeneca (AZ) is a biopharmaceutical company formed in 1999 following the merger two existing European international pharmaceutical companies: Astra AB, a Swedish company founded in 1913, and Zeneca Group PLC, a British company founded in 1993 (as a subsidiary of Imperial Chemical Industries, a British company founded in 1926) [1]. Since 2013, AstraZeneca has been headquartered in … AstraZeneca remains the largest minority shareholder.